{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:12:53Z","timestamp":1788397973083,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To report a case of autoimmune retinopathy (AIR) with multiple systemic involvement<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A 45-year-old Asian Indian male presented with progressive blurring of vision in the right eye for five years. Initial best-corrected visual acuity (BCVA) was 20\/80 in RE and 20\/25 in LE. Clinical evaluation was normal except for a few pigmentary alterations in the periphery. Optical coherence tomography (OCT) later revealed ellipsoid zone loss, and fundus fluorescein angiography showed peripheral venular leakage. Uveitis workup was negative except for a positive T-spot TB; Anti-tubercular therapy for nine months didn\u2019t improve the symptoms, with BCVA declining to 20\/400 in RE. Fundus autofluorescence demonstrated hypo-autofluorescence in the macula surrounded by hyper-autofluorescence. Review of history revealed dermatological features, including alopecia areata and scalp vitiligo, followed by ocular disease and systemic autoimmune abnormalities. The history also indicated onset about two months after COVID-19 vaccination. Antiretinal and other systemic antibodies were positive. The patient was diagnosed with auto immune retinopathy (AIR) and treated with mycophenolate mofetil, escalating to 1.5 g twice daily. At final follow-up 6 months later, BCVA improved to 20\/200 in RE and remained stable in LE, with reduced autofluorescence abnormalities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We report a case of multi system autoimmune disease initially presenting with dermatological features, followed by ocular and other systemic features which may have been triggered following COVID-19 vaccination in an otherwise healthy Indian male. We propose it could be a temporal event and are unable to prove a causal factor. A combination of multimodal imaging with multi-disciplinary approach helped us to come to a final diagnosis in this arduous journey for the patient.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12348-026-00605-x","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T09:16:08Z","timestamp":1780910168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A rare case of multisystem autoimmune disease presenting with retinopathy and alopecia post COVID-19 vaccination"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9756-1207","authenticated-orcid":false,"given":"Srinivasan","family":"Sanjay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8587-2411","authenticated-orcid":false,"given":"Samanthila","family":"Waduthantri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9119-8443","authenticated-orcid":false,"given":"Manju","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6308-5721","authenticated-orcid":false,"given":"Soon-Phaik","family":"Chee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"605_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12348-023-00358-x","volume":"13","author":"P Mahendradas","year":"2023","unstructured":"Mahendradas P, Mishra SB, Sangoram R, Srinivasan S, Kawali A, Patil A, Shetty R (2023) Ocular manifestations following COVID-19 vaccination. J Ophthalmic Inflamm Infect 13:44. https:\/\/doi.org\/10.1186\/s12348-023-00358-x","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"605_CR2","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.oret.2025.03.024","volume":"9","author":"BS Modjtahedi","year":"2025","unstructured":"Modjtahedi BS, Palestine AG, Jampol LM et al (2025) Guidelines for the diagnosis, management, and study of autoimmune retinopathy from the American Academy of Ophthalmology\u2019s Task Force. Ophthalmol Retina 9:1005\u20131016. https:\/\/doi.org\/10.1016\/j.oret.2025.03.024","journal-title":"Ophthalmol Retina"},{"key":"605_CR3","doi-asserted-by":"publisher","unstructured":"Ahmed F, Tsang SH, Sharma T (2025) Autoimmune retinopathy. In: Tsang SH, Sharma T, Diaconita V (eds) Atlas of Inherited Retinal Diseases. Adv Exp Med Biol 1467. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-031-72230-1_49","DOI":"10.1007\/978-3-031-72230-1_49"},{"key":"605_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3390\/medicina60020249","volume":"60","author":"EA Hurissi","year":"2024","unstructured":"Hurissi EA, Abuallut II, Dibaji MQ, Jaly A, Alhazmi AH, Abuageelah BM, Alameer KM, Alyami YM (2024) Ocular complications after COVID-19 vaccination: a systematic review. Med (Kaunas) 60:249. https:\/\/doi.org\/10.3390\/medicina60020249","journal-title":"Med (Kaunas)"},{"key":"605_CR5","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.3390\/vaccines9121404","volume":"9","author":"YK Lee","year":"2021","unstructured":"Lee YK, Huang YH (2021) Ocular manifestations after receiving COVID-19 vaccine: a systematic review. Vaccines (Basel) 9:1404. https:\/\/doi.org\/10.3390\/vaccines9121404","journal-title":"Vaccines (Basel)"},{"key":"605_CR6","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.3390\/jcm10245960","volume":"10","author":"E Bolletta","year":"2021","unstructured":"Bolletta E, Iannetta D, Mastrofilippo V, De Simone L, Gozzi F, Croci S, Bonacini M, Belloni L, Zerbini A, Adani C, Fontana L, Salvarani C, Cimino L (2021) Uveitis and other ocular complications following COVID-19 vaccination. J Clin Med 10:5960. https:\/\/doi.org\/10.3390\/jcm10245960","journal-title":"J Clin Med"},{"key":"605_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12348-021-00275-x","volume":"12","author":"I Testi","year":"2022","unstructured":"Testi I, Brand\u00e3o-de-Resende C, Agrawal R, Pavesio C, COVID-19 Vaccination Ocular Inflammatory Events Study Group (2022) Ocular inflammatory events following COVID-19 vaccination: a multinational case series. J Ophthalmic Inflamm Infect 12:4. https:\/\/doi.org\/10.1186\/s12348-021-00275-x","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"605_CR8","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1080\/09273948.2023.2182324","volume":"31","author":"S Sanjay","year":"2023","unstructured":"Sanjay S, Handa A, Kawali A, Shetty R, Bhakti Mishra S, Mahendradas P (2023) Scleritis and episcleritis following coronavirus disease (COVID-19) vaccination. Ocul Immunol Inflamm 31:1184\u20131190. https:\/\/doi.org\/10.1080\/09273948.2023.2182324","journal-title":"Ocul Immunol Inflamm"},{"key":"605_CR9","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1016\/j.vaccine.2021.01.054","volume":"39","author":"TP Vogel","year":"2021","unstructured":"Vogel TP, Top KA, Karatzios C, Hilmers DC, Tapia LI, Moceri P, Giovannini-Chami L, Wood N, Chandler RE, Klein NP, Schlaudecker EP, Poli MC, Muscal E, Munoz FM (2021) Multisystem inflammatory syndrome in children and adults (MIS-C\/A): case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 39:3037\u20133049. https:\/\/doi.org\/10.1016\/j.vaccine.2021.01.054","journal-title":"Vaccine"},{"key":"605_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ajo.2016.05.013","volume":"168","author":"AR Fox","year":"2016","unstructured":"Fox AR, Gordon LK, Heckenlively JR et al (2016) Consensus on the diagnosis and management of nonparaneoplastic autoimmune retinopathy using a modified Delphi approach. Am J Ophthalmol 168:183\u2013190. https:\/\/doi.org\/10.1016\/j.ajo.2016.05.013","journal-title":"Am J Ophthalmol"},{"key":"605_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3343\/alm.2019.39.1.3","volume":"39","author":"SB Soh","year":"2019","unstructured":"Soh SB, Aw TC (2019) Laboratory testing in thyroid conditions - pitfalls and clinical utility. Ann Lab Med 39:3\u201314. https:\/\/doi.org\/10.3343\/alm.2019.39.1.3","journal-title":"Ann Lab Med"},{"key":"605_CR12","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.4103\/ijo.IJO_2064_22","volume":"71","author":"S Sanjay","year":"2023","unstructured":"Sanjay S, Kawali A, Mahendradas P (2023) COVID-19 vaccination, dengue hepatitis, and recurrent unilateral anterior uveitis. Indian J Ophthalmol 71:2269\u20132272. https:\/\/doi.org\/10.4103\/ijo.IJO_2064_22","journal-title":"Indian J Ophthalmol"},{"key":"605_CR13","doi-asserted-by":"publisher","first-page":"e243888","DOI":"10.1136\/bcr-2021-243888","volume":"14","author":"A Nune","year":"2021","unstructured":"Nune A, Iyengar KP, Goddard C, Ahmed AE (2021) Multisystem inflammatory syndrome in an adult following the SARS-CoV-2 vaccine (MIS-V). BMJ Case Rep 14:e243888. https:\/\/doi.org\/10.1136\/bcr-2021-243888","journal-title":"BMJ Case Rep"},{"key":"605_CR14","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.3201\/eid2707.210594","volume":"27","author":"MB Salzman","year":"2021","unstructured":"Salzman MB, Huang CW, O\u2019Brien CM, Castillo RD (2021) Multisystem inflammatory syndrome after SARS-CoV-2 infection and COVID-19 vaccination. Emerg Infect Dis 27:1944\u20131948. https:\/\/doi.org\/10.3201\/eid2707.210594","journal-title":"Emerg Infect Dis"},{"key":"605_CR15","doi-asserted-by":"publisher","first-page":"e242060","DOI":"10.1136\/bcr-2021-242060","volume":"14","author":"AK Uwaydah","year":"2021","unstructured":"Uwaydah AK, Hassan NMM, Abu Ghoush MS, Shahin KMM (2021) Adult multisystem inflammatory syndrome in a patient who recovered from COVID-19 postvaccination. BMJ Case Rep 14:e242060. https:\/\/doi.org\/10.1136\/bcr-2021-242060","journal-title":"BMJ Case Rep"},{"key":"605_CR16","doi-asserted-by":"publisher","first-page":"e312","DOI":"10.3346\/jkms.2021.36.e312","volume":"36","author":"JW Park","year":"2021","unstructured":"Park JW, Yu SN, Chang SH, Ahn YH, Jeon MH (2021) Multisystem inflammatory syndrome in an adult after COVID-19 vaccination: a case report and literature review. J Korean Med Sci 36:e312. https:\/\/doi.org\/10.3346\/jkms.2021.36.e312","journal-title":"J Korean Med Sci"},{"key":"605_CR17","doi-asserted-by":"publisher","first-page":"e15516","DOI":"10.1111\/dth.15516","volume":"35","author":"B D\u00edaz-Guimaraens","year":"2022","unstructured":"D\u00edaz-Guimaraens B, Saceda-Corralo D, Hermosa-Gelbard \u00c1, Moreno-Arrones \u00d3M, Dominguez-Santas M, Suarez-Valle A, Va\u00f1\u00f3-Galv\u00e1n S (2022) Imiquimod-enhanced immunotherapy with diphencyprone for patients with alopecia areata. Dermatol Ther 35:e15516. https:\/\/doi.org\/10.1111\/dth.15516","journal-title":"Dermatol Ther"},{"key":"605_CR18","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1007\/s00417-005-0066-8","volume":"244","author":"K Siepmann","year":"2006","unstructured":"Siepmann K, Huber M, St\u00fcbiger N, Deuter C, Zierhut M (2006) Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis: a retrospective analysis of 106 patients. Graefes Arch Clin Exp Ophthalmol 244:788\u2013794. https:\/\/doi.org\/10.1007\/s00417-005-0066-8","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"605_CR19","doi-asserted-by":"publisher","first-page":"R182","DOI":"10.1186\/ar2093","volume":"8","author":"RA Moore","year":"2006","unstructured":"Moore RA, Derry S (2006) Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis. Arthritis Res Ther 8:R182. https:\/\/doi.org\/10.1186\/ar2093","journal-title":"Arthritis Res Ther"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12348-026-00605-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-026-00605-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-026-00605-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:16:58Z","timestamp":1788394618000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12348-026-00605-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["605"],"URL":"https:\/\/doi.org\/10.1186\/s12348-026-00605-x","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"7 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of SINGHEALTH. The requirement for individual informed consent was taken. All clinical data were anonymized before analysis, and no information that could identify individual patient has been published.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication of the patients\u2019 clinical details and clinical images was obtained from the patient.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"51"}}